Wells Fargo Maintains Overweight on Bio-Techne, Lowers Price Target to $62
Benzinga Newsdesk 5 months ago
NewsPrice TargetAnalyst Ratings
Wells Fargo analyst Brandon Couillard maintains Bio-Techne (NASDAQ:TECH) with a Overweight and lowers the price target from $76 to $62.
Wells Fargo analyst Brandon Couillard maintains Bio-Techne (NASDAQ:TECH) with a Overweight and lowers the price target from $76 to $62.